|1.||Tobi, Martin: 7 articles (03/2008 - 02/2002)|
|2.||Lawson, Michael: 4 articles (03/2008 - 03/2004)|
|3.||Ullah, Nadeem: 4 articles (03/2008 - 03/2004)|
|4.||Hatfield, James: 4 articles (03/2008 - 01/2003)|
|5.||Sochacki, Paula: 3 articles (03/2008 - 03/2004)|
|6.||Qureshi, Kashif: 3 articles (03/2008 - 03/2004)|
|7.||Yordanova, Violeta: 2 articles (03/2008 - 04/2005)|
|8.||Yuan, Mei: 2 articles (04/2006 - 10/2003)|
|9.||Lawson, Michael J: 2 articles (01/2003 - 02/2002)|
|10.||McGarrity, Thomas: 1 article (03/2008)|
03/01/2008 - "An anti-adenoma antibody, Adnab-9, may reflect the risk for neoplastic progression in familial hamartomatous polyposis syndromes."
01/01/2003 - "Adnab-9 antibody may identify a field defect in above-average-risk adenoma-bearing patients."
01/01/2003 - "In conclusion, in addition to the morphologic and histologic markers already known, Ki-67, Adnab-9 antibody, and p53 protein may be prognostic indicators useful in follow-up of patients with severely dysplastic colorectal adenomas. "
01/01/2003 - "Correlation of Ki-67, p53, and Adnab-9 immunohistochemical staining and ploidy with clinical and histopathologic features of severely dysplastic colorectal adenomas."
01/01/2001 - "We used a monoclonal antibody (MAb) raised against colonic adenomas, Adnab-9, to identify patients with a better prognosis. "
|2.||Colorectal Neoplasms (Colorectal Cancer)
03/01/2008 - "Adnab-9 labeling of PCs in the epithelial elements of hamartomatous colonic lesions of hereditary hamartomatous syndrome patients reflects the predisposition to colorectal cancer, further justifying early intervention strategies."
02/01/2002 - "Adnab-9 binding correlates with increased colorectal cancer risk associated with a field effect of carcinogenesis."
12/01/1993 - "Mean Adnab-9 binding in effluent samples from colorectal cancer patients even after resection is high as compared with that in normal subjects (P < 0.05). "
09/01/1992 - "Immunohistochemical staining with Adnab-9 shows cytoplasmic reactivity in scattered cells in 4 of 31 adenomatous tissue sections, 0 of 14 sections of colorectal cancer cells, and 1 of 8 normal-appearing colonic mucosa specimens examined. "
09/01/1992 - "Adnab-9 binding in colonic washings (effluent) correlates with the presence of colorectal cancer. "
03/01/2008 - "Of the 36 hyperplastic polyp sections, only four (11%) labeled with Adnab-9 and one (3%) with AD5. "
04/01/2005 - "Compared with hyperplastic polyps, the proportion of other polyps labeled by Adnab-9 or anti-alpha-defensin 5 was higher but this difference was more significant for distal (P = 0.008 for Adnab-9 and P = 0.0001 for anti-alpha-defensin 5) than proximal (P = 0.645 and P = 0.154, respectively) polyps. "
01/01/2003 - "For this purpose we compared theclinical, gross, and histologic characteristics of highly dysplastic index polyps in 42 patients with Ki 67, p53, and Adnab-9 immunostaining and other molecular markers. "
03/01/2008 - "Eighty-nine percent of Peutz-Jeghers syndrome polyps labeled with Adnab-9 compared with 63% for AD5; 88% of familial juvenile polyposis sections also labeled with Adnab-9. "
03/01/2008 - "Retrospective, genetic, and hospital archival tissue immunohistochemistry using Adnab-9, a premalignant marker often found in Paneth-like cells (PCs), was performed on sections of polyps from eight patients with Peutz-Jeghers syndrome, eight patients with familial juvenile polyposis, and 36 hyperplastic polyp control sections. "
01/01/2001 - "Adnab-9 labeling may also be a useful prognostic marker for invasive intraductal papillary mucinous neoplasms."
01/01/2001 - "Prognostic significance of the labeling of Adnab-9 in pancreatic intraductal papillary mucinous neoplasms."
12/01/1993 - "Mucosal origin and shedding of an early colonic tumor marker defined by Adnab-9 monoclonal antibody."
01/01/2001 - "26% of the IPMNs labeled with Adnab-9 as compared to 0% of pancreatic ductal cancers or surrounding benign tissues, (p < 0.001) and 53% of adenomas (p < 0.025). "
09/01/1992 - "Adnab-9 binding by enzyme-linked immunosorbent assay in adenomatous extracts is higher than cancer or normal tissue, is membrane-bound, and is absent from established colorectal cancer cell lines. "
01/01/2001 - "Adnab-9 labeling-characteristics appear similar for both IPMNs and adenomatous polyps, suggesting that they are analogous lesions. "
05/15/1990 - "Adnab-9 was tested against pre-colonoscopic effluent material obtained from groups of patients with a macroscopically normal colonscopic examination, histologically confirmed adenomatous polyps and patients with colorectal cancer (CRC). "
|5.||Biotin (Vitamin H)